BioRestorative Therapies, Inc.
BRTX
$2.74
-$0.06-2.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.15M | -3.21M | -3.04M | -2.66M | -5.34M |
| Total Depreciation and Amortization | 52.40K | 52.80K | 52.60K | 52.70K | 51.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -936.00K | -155.80K | -271.50K | -179.60K | 2.54M |
| Change in Net Operating Assets | -769.80K | 895.40K | 356.00K | 89.30K | -31.20K |
| Cash from Operations | -3.81M | -2.42M | -2.90M | -2.69M | -2.78M |
| Capital Expenditure | -- | -79.70K | 0.00 | 0.00 | -36.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 968.40K | 2.48M | 2.00M | 2.13M | 2.40M |
| Cash from Investing | 968.40K | 2.40M | 2.00M | 2.13M | 2.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -178.00K | 72.80K | -- | -- |
| Issuance of Common Stock | 5.00M | 1.08M | 0.00 | 1.90M | 1.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -559.20K | -143.10K | -171.40K | -39.20K | -33.60K |
| Cash from Financing | 4.44M | 923.20K | -49.30K | 888.10K | 1.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.60M | 908.70K | -952.80K | 326.50K | 680.90K |